{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:44:50Z","timestamp":1793259890287,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173268"],"award-info":[{"award-number":["82173268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303162"],"award-info":[{"award-number":["82303162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Lon protease 1 (LONP1) is an ATP-dependent protease located in the mitochondrial matrix and plays a crucial role in regulating mitochondrial proteostasis, metabolism, and cellular stress responses et al. Aberrant LONP1 expression has been found in the progression of various tumors; however, the role and molecular mechanisms of LONP1 in prostate cancer (PCa) remain poorly understood. Here we show that overexpression of LONP1 is closely related to adverse clinic pathological features and poor prognosis in PCa patients. Mechanistically, the findings reveal that LONP1 is implicated in modulating the metabolic switch from oxidative phosphorylation (OXPHOS) to aerobic glycolysis, thereby promoting tumor proliferation, invasion, and metastasis both in vitro and in vivo. Meanwhile, we prove that LONP1 as a protease directly targets mitochondrial pyruvate carrier 1 (MPC1), a key metabolic protein in the process of glycolysis, and enhances its degradation, which in turn suppresses tricarboxylic acid (TCA) cycle and ultimately promotes the progression of PCa. Furthermore, using PCa in cancer-prone mice homozygous for a prostate-targeted conditional\n                    <jats:italic>Pten<\/jats:italic>\n                    knockout and\n                    <jats:italic>Lonp1<\/jats:italic>\n                    knockin, we integrate transcriptomic and proteomic analyses of prostate tumors, upon which reveals that\n                    <jats:italic>Lonp1<\/jats:italic>\n                    overexpression results in a significant downregulation of NADH: ubiquinone oxidoreductase activity, consequently impeding the electron transfer process and mitochondrial ATP synthesis, associated with metastasis of PCa. Collectively, our results highlight that metabolic reprogramming induced by LONP1 in PCa is closely coupled with disease progression, suggesting that targeting the LONP1-mediated cascade in the mitochondrial may provide therapeutic potential for PCa disease.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-07449-8","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T16:26:01Z","timestamp":1739982361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Mengfei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mierxiati","family":"Abudurexiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6546-9334","authenticated-orcid":false,"given":"Gong-hong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-6505","authenticated-orcid":false,"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"7449_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen S, Zhu G, Yang Y, Wang F, Xiao YT, Zhang N, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol. 2021;23:87\u201398.","journal-title":"Nat Cell Biol"},{"key":"7449_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"7449_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47\u201353.","journal-title":"J Natl Cancer Cent"},{"key":"7449_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mito.2005.02.001","volume":"5","author":"LC Costello","year":"2005","unstructured":"Costello LC, Franklin RB, Feng P. Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer. Mitochondrion. 2005;5:143\u201353.","journal-title":"Mitochondrion"},{"key":"7449_CR5","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.2741\/1692","volume":"10","author":"RB Franklin","year":"2005","unstructured":"Franklin RB, Milon B, Feng P, Costello LC. Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer. Front Biosci. 2005;10:2230\u20139.","journal-title":"Front Biosci"},{"key":"7449_CR6","doi-asserted-by":"publisher","first-page":"28875","DOI":"10.1074\/jbc.272.46.28875","volume":"272","author":"LC Costello","year":"1997","unstructured":"Costello LC, Liu Y, Franklin RB, Kennedy MC. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem. 1997;272:28875\u201381.","journal-title":"J Biol Chem"},{"key":"7449_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.mam.2012.11.007","volume":"34","author":"MC Franz","year":"2013","unstructured":"Franz MC, Anderle P, B\u00fcrzle M, Suzuki Y, Freeman MR, Hediger MA, et al. Zinc transporters in prostate cancer. Mol Asp Med. 2013;34:735\u201341.","journal-title":"Mol Asp Med"},{"key":"7449_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ijc.21411","volume":"118","author":"KH Tsui","year":"2006","unstructured":"Tsui KH, Chang PL, Juang HH. Zinc blocks gene expression of mitochondrial aconitase in human prostatic carcinoma cells. Int J Cancer. 2006;118:609\u201315.","journal-title":"Int J Cancer"},{"key":"7449_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fphys.2017.00097","volume":"8","author":"F Cutruzzol\u00e0","year":"2017","unstructured":"Cutruzzol\u00e0 F, Giardina G, Marani M, Macone A, Paiardini A, Rinaldo S, et al. Glucose metabolism in the progression of prostate cancer. Front Physiol. 2017;8:97.","journal-title":"Front Physiol"},{"key":"7449_CR10","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/med.21766","volume":"41","author":"HJ Cardoso","year":"2021","unstructured":"Cardoso HJ, Carvalho TMA, Fonseca LRS, Figueira MI, Vaz CV, Socorro S. Revisiting prostate cancer metabolism: from metabolites to disease and therapy. Med Res Rev. 2021;41:1499\u2013538.","journal-title":"Med Res Rev"},{"key":"7449_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0969-8051(96)00044-3","volume":"23","author":"SD Yeh","year":"1996","unstructured":"Yeh SD, Imbriaco M, Larson SM, Garza D, Zhang JJ, Kalaigian H, et al. Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. Nucl Med Biol. 1996;23:693\u20137.","journal-title":"Nucl Med Biol"},{"key":"7449_CR12","doi-asserted-by":"publisher","first-page":"e00412","DOI":"10.1128\/MCB.00412-17","volume":"38","author":"O Zurita Rend\u00f3n","year":"2018","unstructured":"Zurita Rend\u00f3n O, Shoubridge EA. LONP1 is required for maturation of a subset of mitochondrial proteins, and its loss elicits an integrated stress response. Mol Cell Biol. 2018;38:e00412\u20137.","journal-title":"Mol Cell Biol"},{"key":"7449_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbamcr.2011.11.003","volume":"1823","author":"S Venkatesh","year":"2012","unstructured":"Venkatesh S, Lee J, Singh K, Lee I, Suzuki CK. Multitasking in the mitochondrion by the ATP-dependent Lon protease. Biochim Biophys Acta. 2012;1823:56\u201366.","journal-title":"Biochim Biophys Acta"},{"key":"7449_CR14","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","volume":"28","author":"S Pickles","year":"2018","unstructured":"Pickles S, Vigi\u00e9 P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol. 2018;28:R170\u2013r85.","journal-title":"Curr Biol"},{"key":"7449_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2020.02.005","volume":"354","author":"L Gibellini","year":"2020","unstructured":"Gibellini L, De Gaetano A, Mandrioli M, Van Tongeren E, Bortolotti CA, Cossarizza A, et al. The biology of Lonp1: more than a mitochondrial protease. Int Rev Cell Mol Biol. 2020;354:1\u201361.","journal-title":"Int Rev Cell Mol Biol"},{"key":"7449_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/ncb836","volume":"4","author":"DA Bota","year":"2002","unstructured":"Bota DA, Davies KJ. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol. 2002;4:674\u201380.","journal-title":"Nat Cell Biol"},{"key":"7449_CR17","doi-asserted-by":"publisher","first-page":"18410","DOI":"10.1073\/pnas.1008924107","volume":"107","author":"Y Matsushima","year":"2010","unstructured":"Matsushima Y, Goto Y, Kaguni LS. Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM). Proc Natl Acad Sci USA. 2010;107:18410\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7449_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0014-5793(02)03638-4","volume":"532","author":"DA Bota","year":"2002","unstructured":"Bota DA, Van Remmen H, Davies KJ. Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett. 2002;532:103\u20136.","journal-title":"FEBS Lett"},{"key":"7449_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/2211-5463.13108","volume":"11","author":"CC Ferezin","year":"2021","unstructured":"Ferezin CC, Basei FL, Melo-Hanchuk TD, De Oliveira AL, Peres De Oliveira A, Mori MP, et al. NEK5 interacts with LonP1 and its kinase activity is essential for the regulation of mitochondrial functions and mtDNA maintenance. FEBS Open Bio. 2021;11:546\u201363.","journal-title":"FEBS Open Bio"},{"key":"7449_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaz8240","volume":"13","author":"J Li","year":"2020","unstructured":"Li J, Agarwal E, Bertolini I, Seo JH, Caino MC, Ghosh JC, et al. The mitophagy effector FUNDC1 controls mitochondrial reprogramming and cellular plasticity in cancer cells. Sci Signal. 2020;13:eaaz8240.","journal-title":"Sci Signal"},{"key":"7449_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1146\/annurev-biochem-062917-012739","volume":"89","author":"S Deshwal","year":"2020","unstructured":"Deshwal S, Fiedler KU, Langer T. Mitochondrial proteases: multifaceted regulators of mitochondrial plasticity. Annu Rev Biochem. 2020;89:501\u201328.","journal-title":"Annu Rev Biochem"},{"key":"7449_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.9","volume":"6","author":"TY Kao","year":"2015","unstructured":"Kao TY, Chiu YC, Fang WC, Cheng CW, Kuo CY, Juan HF, et al. Mitochondrial Lon regulates apoptosis through the association with Hsp60-mtHsp70 complex. Cell Death Dis. 2015;6:e1642.","journal-title":"Cell Death Dis"},{"key":"7449_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0730-7","volume":"9","author":"YJ Sung","year":"2018","unstructured":"Sung YJ, Kao TY, Kuo CL, Fan CC, Cheng AN, Fang WC, et al. Mitochondrial Lon sequesters and stabilizes p53 in the matrix to restrain apoptosis under oxidative stress via its chaperone activity. Cell Death Dis. 2018;9:697.","journal-title":"Cell Death Dis"},{"key":"7449_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1126\/science.274.5284.103","volume":"274","author":"M Rep","year":"1996","unstructured":"Rep M, Van Dijl JM, Suda K, Schatz G, Grivell LA, Suzuki CK. Promotion of mitochondrial membrane complex assembly by a proteolytically inactive yeast Lon. Science. 1996;274:103\u20136.","journal-title":"Science"},{"key":"7449_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1126\/science.8146662","volume":"264","author":"CK Suzuki","year":"1994","unstructured":"Suzuki CK, Suda K, Wang N, Schatz G. Requirement for the yeast gene LON in intramitochondrial proteolysis and maintenance of respiration. Science. 1994;264:273\u20136.","journal-title":"Science"},{"key":"7449_CR26","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1101\/gad.12.10.1515","volume":"12","author":"L Van Dyck","year":"1998","unstructured":"Van Dyck L, Neupert W, Langer T. The ATP-dependent PIM1 protease is required for the expression of intron-containing genes in mitochondria. Genes Dev. 1998;12:1515\u201324.","journal-title":"Genes Dev"},{"key":"7449_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.celrep.2014.06.018","volume":"8","author":"PM Quir\u00f3s","year":"2014","unstructured":"Quir\u00f3s PM, Espa\u00f1ol Y, Ac\u00edn-P\u00e9rez R, Rodr\u00edguez F, B\u00e1rcena C, Watanabe K, et al. ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity. Cell Rep. 2014;8:542\u201356.","journal-title":"Cell Rep"},{"key":"7449_CR28","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/ajmg.a.37029","volume":"167","author":"E Dikoglu","year":"2015","unstructured":"Dikoglu E, Alfaiz A, Gorna M, Bertola D, Chae JH, Cho TJ, et al. Mutations in LONP1, a mitochondrial matrix protease, cause CODAS syndrome. Am J Med Genet A. 2015;167:1501\u20139.","journal-title":"Am J Med Genet A"},{"key":"7449_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajhg.2014.12.003","volume":"96","author":"KA Strauss","year":"2015","unstructured":"Strauss KA, Jinks RN, Puffenberger EG, Venkatesh S, Singh K, Cheng I, et al. CODAS syndrome is associated with mutations of LONP1, encoding mitochondrial AAA+ Lon protease. Am J Hum Genet. 2015;96:121\u201335.","journal-title":"Am J Hum Genet"},{"key":"7449_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/jhg.2017.11","volume":"62","author":"T Inui","year":"2017","unstructured":"Inui T, Anzai M, Takezawa Y, Endo W, Kakisaka Y, Kikuchi A, et al. A novel mutation in the proteolytic domain of LONP1 causes atypical CODAS syndrome. J Hum Genet. 2017;62:653\u201355.","journal-title":"J Hum Genet"},{"key":"7449_CR31","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1038\/s41388-019-0939-7","volume":"38","author":"JC Ghosh","year":"2019","unstructured":"Ghosh JC, Seo JH, Agarwal E, Wang Y, Kossenkov AV, Tang HY, et al. Akt phosphorylation of mitochondrial Lonp1 protease enables oxidative metabolism and advanced tumor traits. Oncogene. 2019;38:6926\u201339.","journal-title":"Oncogene"},{"key":"7449_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-981-10-6674-0_12","volume":"1038","author":"B Lu","year":"2017","unstructured":"Lu B. Mitochondrial Lon protease and cancer. Adv Exp Med Biol. 2017;1038:173\u201382.","journal-title":"Adv Exp Med Biol"},{"key":"7449_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","volume":"19","author":"LA Byers","year":"2013","unstructured":"Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res. 2013;19:279\u201390.","journal-title":"Clin Cancer Res"},{"key":"7449_CR34","unstructured":"Romero N, Swain P, Neilson A, Dranka B Improving quantification of cellular glycolytic rate using Agilent Seahorse XF technology. Agilent Technologies White Paper. 2017."},{"key":"7449_CR35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm3984","volume":"16","author":"PM Quir\u00f3s","year":"2015","unstructured":"Quir\u00f3s PM, Langer T, L\u00f3pez-Ot\u00edn C. New roles for mitochondrial proteases in health, ageing and disease. Nat Rev Mol Cell Biol. 2015;16:345\u201359.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7449_CR36","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1007\/s00018-015-2039-3","volume":"72","author":"M Pinti","year":"2015","unstructured":"Pinti M, Gibellini L, Liu Y, Xu S, Lu B, Cossarizza A. Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer. Cell Mol Life Sci. 2015;72:4807\u201324.","journal-title":"Cell Mol Life Sci"},{"key":"7449_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23495-0","volume":"12","author":"M Shin","year":"2021","unstructured":"Shin M, Watson ER, Song AS, Mindrebo JT, Novick SJ, Griffin PR, et al. Structures of the human LONP1 protease reveal regulatory steps involved in protease activation. Nat Commun. 2021;12:3239.","journal-title":"Nat Commun"},{"key":"7449_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1126\/science.1218099","volume":"337","author":"DK Bricker","year":"2012","unstructured":"Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, Chen YC, et al. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science. 2012;337:96\u2013100.","journal-title":"Science"},{"key":"7449_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.1218530","volume":"337","author":"S Herzig","year":"2012","unstructured":"Herzig S, Raemy E, Montessuit S, Veuthey JL, Zamboni N, Westermann B, et al. Identification and functional expression of the mitochondrial pyruvate carrier. Science. 2012;337:93\u20136.","journal-title":"Science"},{"key":"7449_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.freeradbiomed.2020.11.035","volume":"163","author":"C Wang","year":"2021","unstructured":"Wang C, Dong L, Li X, Li Y, Zhang B, Wu H, et al. The PGC1\u03b1\/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib\/doxorubicin treatment in hepatocellular carcinoma. Free Radic Biol Med. 2021;163:141\u201352.","journal-title":"Free Radic Biol Med"},{"key":"7449_CR41","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1042\/BCJ20170967","volume":"475","author":"E Koh","year":"2018","unstructured":"Koh E, Kim YK, Shin D, Kim KS. MPC1 is essential for PGC-1\u03b1-induced mitochondrial respiration and biogenesis. Biochem J. 2018;475:1687\u201399.","journal-title":"Biochem J"},{"key":"7449_CR42","doi-asserted-by":"publisher","first-page":"14673","DOI":"10.18632\/oncotarget.7405","volume":"7","author":"L Wang","year":"2016","unstructured":"Wang L, Xu M, Qin J, Lin SC, Lee HJ, Tsai SY, et al. MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer. Oncotarget. 2016;7:14673\u201383.","journal-title":"Oncotarget"},{"key":"7449_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1324-8","volume":"10","author":"H Zou","year":"2019","unstructured":"Zou H, Chen Q, Zhang A, Wang S, Wu H, Yuan Y, et al. MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway. Cell Death Dis. 2019;10:148.","journal-title":"Cell Death Dis"},{"key":"7449_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2941-6","volume":"16","author":"X Li","year":"2016","unstructured":"Li X, Ji Y, Han G, Li X, Fan Z, Li Y, et al. MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer. BMC Cancer. 2016;16:894.","journal-title":"BMC Cancer"},{"key":"7449_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2011.11.188","volume":"105","author":"H Pagniez-Mammeri","year":"2012","unstructured":"Pagniez-Mammeri H, Loublier S, Legrand A, B\u00e9nit P, Rustin P, Slama A. Mitochondrial complex I deficiency of nuclear origin I. Structural genes. Mol Genet Metab. 2012;105:163\u201372.","journal-title":"Mol Genet Metab"},{"key":"7449_CR46","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.bbabio.2006.10.001","volume":"1757","author":"A Galkin","year":"2006","unstructured":"Galkin A, Dr\u00f6se S, Brandt U. The proton pumping stoichiometry of purified mitochondrial complex I reconstituted into proteoliposomes. Biochim Biophys Acta. 2006;1757:1575\u201381.","journal-title":"Biochim Biophys Acta"},{"key":"7449_CR47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.1191046","volume":"329","author":"C Hunte","year":"2010","unstructured":"Hunte C, Zickermann V, Brandt U. Functional modules and structural basis of conformational coupling in mitochondrial complex I. Science. 2010;329:448\u201351.","journal-title":"Science"},{"key":"7449_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34:355\u201377.","journal-title":"Cell Metab"},{"key":"7449_CR49","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1113\/JP278810","volume":"599","author":"P Vaupel","year":"2021","unstructured":"Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol. 2021;599:1745\u201357.","journal-title":"J Physiol"},{"key":"7449_CR50","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3390\/cells9102308","volume":"9","author":"JH Park","year":"2020","unstructured":"Park JH, Pyun WY, Park HW. Cancer metabolism: phenotype, signaling and therapeutic targets. Cells. 2020;9:2380.","journal-title":"Cells"},{"key":"7449_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101719","volume":"298","author":"J Lee","year":"2022","unstructured":"Lee J, Pandey AK, Venkatesh S, Thilagavathi J, Honda T, Singh K, et al. Inhibition of mitochondrial LonP1 protease by allosteric blockade of ATP binding and hydrolysis via CDDO and its derivatives. J Biol Chem. 2022;298:101719.","journal-title":"J Biol Chem"},{"key":"7449_CR52","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1124\/pr.111.004846","volume":"64","author":"KT Liby","year":"2012","unstructured":"Liby KT, Sporn MB. Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharm Rev. 2012;64:972\u20131003.","journal-title":"Pharm Rev"},{"key":"7449_CR53","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1074\/jbc.M116.754127","volume":"292","author":"C Crewe","year":"2017","unstructured":"Crewe C, Schafer C, Lee I, Kinter M, Szweda LI. Regulation of pyruvate dehydrogenase kinase 4 in the heart through degradation by the lon protease in response to mitochondrial substrate availability. J Biol Chem. 2017;292:305\u201312.","journal-title":"J Biol Chem"},{"key":"7449_CR54","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1083\/jcb.200108103","volume":"157","author":"O Hori","year":"2002","unstructured":"Hori O, Ichinoda F, Tamatani T, Yamaguchi A, Sato N, Ozawa K, et al. Transmission of cell stress from endoplasmic reticulum to mitochondria: enhanced expression of Lon protease. J Cell Biol. 2002;157:1151\u201360.","journal-title":"J Cell Biol"},{"key":"7449_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.204","volume":"4","author":"CW Cheng","year":"2013","unstructured":"Cheng CW, Kuo CY, Fan CC, Fang WC, Jiang SS, Lo YK, et al. Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species. Cell Death Dis. 2013;4:e681.","journal-title":"Cell Death Dis"},{"key":"7449_CR56","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1172\/JCI64264","volume":"123","author":"AF Santidrian","year":"2013","unstructured":"Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, Leboeuf SE, Gay LJ, et al. Mitochondrial complex I activity and NAD+\/NADH balance regulate breast cancer progression. J Clin Invest. 2013;123:1068\u201381.","journal-title":"J Clin Invest"},{"key":"7449_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01682-2","volume":"16","author":"Y Hu","year":"2024","unstructured":"Hu Y, He Z, Li Z, Wang Y, Wu N, Sun H, et al. Lactylation: the novel histone modification influence on gene expression, protein function, and disease. Clin Epigenetics. 2024;16:72.","journal-title":"Clin Epigenetics"},{"key":"7449_CR58","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07449-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07449-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07449-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T16:28:04Z","timestamp":1739982484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07449-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7449"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07449-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments conducted were compliant with Ethics Committee of Fudan University Shanghai Cancer Center (FUSCC-IACUC-S20210421).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"116"}}